Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
11/29/1989 | EP0343248A1 Novel polypeptide and method for preparing the same |
11/29/1989 | EP0343186A1 MOLECULES COMPRISING AT LEAST ONE PEPTIDIC SEQUENCE CARRYING ONE OR A PLURALITY OF EPITOPES CHARACTERIZING A PROTEIN PRODUCED BY -i(P. FALCIPARUM) IN HEPATOCYTES AND COMPOSITIONS CONTAINING THEM. |
11/28/1989 | US4883861 Cysteine-rich peptides having gamma-glutamic acid and beta-alanine units, a process for their preparation and their use |
11/28/1989 | CA1263500A1 Gnrh antagonists ii |
11/28/1989 | CA1263329A1 Biologically active substances obtained from bovine casein, process for their preparation and compounds containing the same |
11/23/1989 | EP0343137A1 Fibronectin binding protein |
11/23/1989 | EP0343100A2 Process for the isolation and characterization of a gene-enzyme system for the inactivation of the herbicide phenmedipham |
11/23/1989 | EP0342962A2 Peptides having T cell helper activity |
11/23/1989 | EP0342541A2 Retroviral protease inhibitors |
11/23/1989 | DE3915317A1 Verwendung von gonadoliberinderivaten Use of gonadoliberinderivaten |
11/21/1989 | US4882419 Process for preparing antibiotic L 17392 (deglucoteicoplanin) |
11/21/1989 | US4882313 Carboxamide derivatives of glycopeptides |
11/21/1989 | US4882145 T cell epitopes of the hepatitis B virus nucleocapsid protein |
11/16/1989 | WO1989010961A1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
11/16/1989 | WO1989010939A1 Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens |
11/16/1989 | WO1989010933A1 Polypeptide compounds having growth hormone releasing activity |
11/16/1989 | WO1989010760A1 Synthetic peptides for arterial imaging |
11/16/1989 | WO1989010754A1 Therapeutic methods using catalytic antibodies |
11/16/1989 | WO1989010752A1 Retroviral protease inhibitors |
11/16/1989 | WO1989010735A1 Probursin |
11/15/1989 | EP0342015A2 Peptides, their use and pharmaceutical compositions containing them |
11/15/1989 | EP0341915A2 Anti-aggregatory peptides |
11/15/1989 | EP0341607A2 Anticoagulant peptide alcohols |
11/15/1989 | EP0341444A2 Rapid mutational analysis method |
11/15/1989 | EP0341311A1 Hexapeptide and pharmaceutical preparation based thereon for curing erosive-ulcerous injuries to the digestive tract |
11/15/1989 | EP0341287A1 Diagnostic methods and systems for quantifying apo ai |
11/15/1989 | CN1037156A Peptide compounds, process for preparing same and pharmaceutical composition containing same |
11/14/1989 | US4880812 Antitumor agents |
11/14/1989 | US4880778 Combinations having synergistic growth hormone releasing activity and methods for use thereof |
11/08/1989 | EP0340741A2 Polyethylene glycol derivatives, modified peptides and production thereof |
11/07/1989 | US4879213 Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse |
11/07/1989 | US4879212 Peptide composition and method for the detection of antibodies to HTLV-III |
11/07/1989 | CA1262799A1 Broad spectrum vaccine against gonorrhea |
11/02/1989 | WO1989010348A1 Fatty amino acids, and homo- and hetero-oligomers and conjugates thereof |
11/02/1989 | WO1989010135A1 Hybrid peptides and methods of their use |
11/02/1989 | WO1989010134A1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
11/02/1989 | WO1989010098A1 Stimulation of chemotaxis by chemotactic peptides |
11/02/1989 | EP0339982A1 Antibiotic compounds |
11/02/1989 | EP0339695A2 A process for preparing an antigenic or immunogenic conjugate as well as the use of such conjugates |
11/02/1989 | EP0339549A2 Tyr-peptide analogs |
11/02/1989 | EP0339504A2 Human immunodeficiency virus (HIV) env-coded peptide capable of eliciting HIV-inhibiting antibodies in mammals |
11/02/1989 | EP0339193A1 Peptide ligands for bombesin receptors |
11/01/1989 | CN1036795A 肽衍生物 Peptide derivatives |
10/31/1989 | US4877830 Chromatography of proteins |
10/25/1989 | EP0338634A2 Viper venom polypeptides and genetic expression |
10/25/1989 | EP0338062A1 Drug comprising the association of polymyxin b, tobramycin and amphotericin b administered by spraying |
10/24/1989 | US4876332 Heparin binders; cellular adhesion promoters; coatings for medical equipment and bandages |
10/24/1989 | US4876243 Diuretics |
10/19/1989 | WO1989009818A1 Processes for purifying phospholipase a2 and producing phospholipase a2-like polypeptides |
10/19/1989 | WO1989009788A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
10/19/1989 | WO1989009787A2 Osteogenic devices |
10/19/1989 | WO1989009786A1 Peptide derivatives |
10/19/1989 | WO1989009785A1 Peptides inhibitors of hiv induced cell fusions and syncytia formation |
10/19/1989 | WO1989009783A1 Polypeptides stabilized by covalent hydrogen bond replacements |
10/19/1989 | WO1989009611A1 Cyclic analogs of atrial natriuretic peptides |
10/18/1989 | EP0337731A2 Peptide antibiotics |
10/18/1989 | EP0337203A2 Aglycons of A/16686 antibiotics |
10/18/1989 | EP0336976A1 Pharmaceutical preparation for curing multiple sclerosis and lateral amyotrophic sclerosis |
10/17/1989 | US4874843 Chromatographic purification process |
10/17/1989 | CA1262399A1 Gnrh antagonists |
10/11/1989 | EP0336779A2 Polypeptides stabilized by covalent hydrogen bond replacements |
10/11/1989 | EP0336554A1 Novel peptide and salts thereof and peptide antiallergic agents containing these peptides |
10/11/1989 | EP0336230A2 Cyclic peptide antagonists of Substance P and Substance K |
10/05/1989 | WO1989009403A1 Diagnostic methods and systems for quantifying apo ai |
10/05/1989 | WO1989009231A1 Therapeutic peptides |
10/05/1989 | WO1989009230A1 Therapeutic peptides |
10/05/1989 | WO1989009228A1 Peptides |
10/05/1989 | WO1989009226A1 Peptides |
10/05/1989 | WO1989009064A1 Synthetic peptides from streptococcal m protein and vaccines prepared therefrom |
10/04/1989 | EP0335662A1 Peptides |
10/04/1989 | EP0335476A2 Recombinant methods for the production of ricin a, ricin b, ricin or diphtheria toxin (dt)a or ab' fragment, suitable hosts and vectors therefor, and conjugates comprising ricin toxin a chain or diphtheria toxin |
10/03/1989 | US4871717 Peptides |
09/27/1989 | EP0334685A2 Bradykinin analogues, their synthesis and their use in therapy |
09/27/1989 | EP0334244A2 Bradykinin Antagonist Peptides |
09/26/1989 | US4870161 Reagents and probes for distinguishing and isolating different GTP-binding proteins |
09/26/1989 | US4870160 Polypeptides with laminin activity |
09/26/1989 | CA1262010A1 Amino thiol peptides |
09/26/1989 | CA1261548A1 Cyclic octapeptides and pharmaceutical preparations thereof, as well as processes for their manufacture, and their use |
09/21/1989 | WO1989008662A1 General cancer-associated scm-recognition factor, preparation and method of use |
09/20/1989 | EP0333517A2 Method and agent for inhibiting the binding of human polymorphonuclear leukocytes to endothelium and compositions therefor |
09/20/1989 | EP0333071A2 Polypeptides, methods for their preparation, pharmaceutical compositions comprising them and use |
09/20/1989 | EP0332912A2 Inhibition of cell migration with synthetic peptides |
09/20/1989 | EP0332688A1 Bradykinin antagonist peptides |
09/20/1989 | CN1035679A Nanbv diagnostics and vaccines |
09/19/1989 | US4868287 Inhibition of mineral deposition by polyanionic/hydrophobic peptides and derivatives thereof having a clustered block copolymer structure |
09/19/1989 | US4868171 Antibiotic A 40926 N-acylaminoglucuronyl aglycons and antiobiotic A 40926 aglycon |
09/13/1989 | EP0332225A2 Antibody to polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
09/12/1989 | US4866160 Therapeutic decapeptides |
09/12/1989 | US4866039 Peptides containing the 18 to 23 residues of vasoactive intestinal peptide, and analogues |
09/12/1989 | CA1259449A1 Serum thymic factor peptide analogs and a process for the preparation thereof |
09/08/1989 | WO1989008118A1 Synthetic scm-active cancer recognition peptides |
09/06/1989 | EP0331184A2 Peptide equivalents of non-peptides and methods of design therefor |
09/06/1989 | EP0331073A2 Benzhydrylamine derivatives |
09/06/1989 | EP0330878A2 Anti-ras protein-antibodies |
09/06/1989 | EP0330667A1 Peptide compounds |
09/05/1989 | US4864019 Antibodies to inhibin and conjugates produced therefrom |
09/05/1989 | US4863899 Biologically active polypeptides |
09/05/1989 | US4863857 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known |
08/30/1989 | EP0330241A2 Calcitonin derivatives |
08/30/1989 | EP0329994A1 Immunogen and its use in preparing antibodies to haemoglobin A1C |